State Street
HRMY icon

State Street’s Harmony Biosciences HRMY Stock Holding History

State Street’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.7M Buy
1,859,322
+74,960
+4% +$2.36M ﹤0.01% 1691
2026
Q1 		$50M Buy
1,784,362
+122,512
+7% +$4.02M ﹤0.01% 1742
2025
Q4 		$62.2M Buy
1,661,850
+8,246
+0.5% +$271K ﹤0.01% 1621
2025
Q3 		$45.6M Buy
1,653,604
+24,358
+1% +$839K ﹤0.01% 1770
2025
Q2 		$51.5M Buy
1,629,246
+50,212
+3% +$1.62M ﹤0.01% 1662
2025
Q1 		$52.4M Sell
1,579,034
-1,781
-0.1% -$63.8K ﹤0.01% 1602
2024
Q4 		$54.4M Buy
1,580,815
+340,217
+27% +$11.7M ﹤0.01% 1676
2024
Q3 		$49.6M Sell
1,240,598
-32,900
-3% -$1.16M ﹤0.01% 1711
2024
Q2 		$38.4M Sell
1,273,498
-22,046
-2% -$663K ﹤0.01% 1795
2024
Q1 		$43.5M Sell
1,295,544
-64,903
-5% -$2.08M ﹤0.01% 1789
2023
Q4 		$43.9M Buy
1,360,447
+132,986
+11% +$3.71M ﹤0.01% 1776
2023
Q3 		$40.2M Buy
1,227,461
+86,527
+8% +$3M ﹤0.01% 1760
2023
Q2 		$40.1M Buy
1,140,934
+97,337
+9% +$3.36M ﹤0.01% 1801
2023
Q1 		$34.1M Buy
1,043,597
+70,814
+7% +$3.22M ﹤0.01% 1883
2022
Q4 		$53.6M Sell
972,783
-104,043
-10% -$5.72M ﹤0.01% 1586
2022
Q3 		$47.7M Buy
1,076,826
+132,491
+14% +$6.46M ﹤0.01% 1623
2022
Q2 		$46.1M Buy
944,335
+116,154
+14% +$5.23M ﹤0.01% 1701
2022
Q1 		$40.3M Buy
828,181
+52,498
+7% +$2.14M ﹤0.01% 1898
2021
Q4 		$33.1M Buy
775,683
+378,825
+95% +$15.1M ﹤0.01% 2106
2021
Q3 		$15.2M Buy
396,858
+94,068
+31% +$3.03M ﹤0.01% 2642
2021
Q2 		$8.55M Buy
302,790
+215,312
+246% +$6.46M ﹤0.01% 2994
2021
Q1 		$2.89M Buy
87,478
+4,700
+6% +$165K ﹤0.01% 3284
2020
Q4 		$2.99M Buy
+82,778
New +$3.34M ﹤0.01% 3194

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street's HRMY Position: Q2 2026 in Review

State Street increased its Harmony Biosciences (HRMY) stake by 4.2% in Q2 2026, buying an estimated $2.36M and bringing the position to 1,859,322 shares worth $67.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1691.

State Street first reported a position in HRMY in Q4 2020 and has held it in 23 quarters since. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • State Street held 1,859,322 shares of Harmony Biosciences worth $67.7M as of Q2 2026.
  • State Street bought 74,960 Harmony Biosciences shares in Q2 2026, an estimated $2.36M.
  • Harmony Biosciences made up ﹤0.01% of State Street's portfolio in Q2 2026, its #1691 holding.
  • State Street first reported a position in Harmony Biosciences in Q4 2020 and has held it in 23 quarters since.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.